Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
658
NCT00112281
A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2005
Completion: Jan 31, 2007